1. Lee LN, Lyford-Pike S, Boahene KD. Traumatic facial nerve injury. Otolaryngol Clin North Am. 2013;46(5):825–39.
2. Cai Z, Yu G, Ma D, Tan J, Yang Z, Zhang X. Experimental studies on traumatic facial nerve injury. J Laryngol Otol. 1998;112(3):243–7.
3. Avilés-Trigueros M, Mayor-Torroglosa S, García-Avilés A, Lafuente MP, Rodríguez ME, Miralles de Imperial J, et al. Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine. Experimental Neurology. 2003;184(2):767–77..
4. Cai J, Li J, Liu W, Han Y, Wang H. α2-adrenergic receptors in spiral ganglion neurons may mediate protective effects of brimonidine and yohimbine against glutamate and hydrogen peroxide toxicity. Neuroscience. 2013;228(1):23–35.
5. Valiente-Soriano FJ, Ortín-Martínez A, Di Pierdomenico J, García-Ayuso D, Gallego-Ortega A, Miralles de Imperial-Ollero JA, et al. Topical brimonidine or intravitreal BDNF, CNTF, or bFGF protect cones against phototoxicity. Trans Vis Sci Tech. 2019;8(6):36.